|Year : 2016 | Volume
| Issue : 4 | Page : 159-165
Anticancer, antioxidant potential and profiling of polyphenolic compounds of Wrightia tinctoria Roxb. (R.Br.) bark
Nishat Fatima1, Mohammad Kaleem Ahmad2, Jamal Akhtar Ansari1, Zulfiqar Ali3, Abdul Rahman Khan3, Abbas Ali Mahdi2
1 Department of Biochemistry, Natural Products Research Laboratory, King George's Medical University; Department of Chemistry, Integral University, Lucknow, Uttar Pradesh, India
2 Department of Biochemistry, Natural Products Research Laboratory, King George's Medical University, Lucknow, Uttar Pradesh, India
3 Department of Chemistry, Integral University, Lucknow, Uttar Pradesh, India
|Date of Web Publication||29-Sep-2016|
Abbas Ali Mahdi
Department of Biochemistry, Natural Products Research Laboratories, King George's Medical University, Lucknow - 226 003, Uttar Pradesh
Source of Support: None, Conflict of Interest: None
Wrightia tinctoria Roxb. (R.Br.) is an Ayurvedic remedy, ethnomedically used in the treatment of various ailments. The present work was carried out to evaluate the anticancer and antioxidant activity as well as total phenolic and phytochemical contents of W. tinctoria bark methanolic extract (WTBM) by high-performance liquid chromatography (HPLC)-diode array detector. Antiproliferative activity of WTBM was evaluated against MDA-MB-231 and MCF-7 cancer cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, colony formation, and Hoechst staining. In addition, the antioxidant potential was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical cation decolorization assay. Total phenolic content was assessed by Folin-Ciocalteu method. The results demonstrated that WTBM exhibited significant antiproliferative effect against MDA-MB-231 (IC 50 = 88.9 ± 1.27 μg/ml) and MCF-7 (IC 50 = 45.71 ± 7.74 μg/ml) cancer cells in time- and dose-dependent manner. WTBM significantly suppresses colony formation and induces apoptosis in both MDA-MB-231 and MCF-7 cells as evident by morphological assessment, clonogenic assay, and Hoechst staining. The total phenolic content of WTBM was found to be 30.3 gallic acid equivalent mg/g dry weight of bark extract while IC 50 value for DPPH and ABTS radical scavenging activity was 72.2 ± 2.8 μg/ml and 45.16 ± 1.95 μg/ml, respectively. HPLC analysis showed the presence of gallic acid, rutin, and quercetin in WTBM. These findings demonstrated that WTBM significantly inhibited proliferation of breast cancer cells and induced apoptosis, suggesting the potential chemopreventive activity of W. tinctoria bark.
Keywords: Antioxidant, antiproliferative, breast cancer, high-performance liquid chromatography, Wrightia tinctoria
|How to cite this article:|
Fatima N, Ahmad MK, Ansari JA, Ali Z, Khan AR, Mahdi AA. Anticancer, antioxidant potential and profiling of polyphenolic compounds of Wrightia tinctoria Roxb. (R.Br.) bark. J Adv Pharm Technol Res 2016;7:159-65
|How to cite this URL:|
Fatima N, Ahmad MK, Ansari JA, Ali Z, Khan AR, Mahdi AA. Anticancer, antioxidant potential and profiling of polyphenolic compounds of Wrightia tinctoria Roxb. (R.Br.) bark. J Adv Pharm Technol Res [serial online] 2016 [cited 2022 Oct 7];7:159-65. Available from: https://www.japtr.org/text.asp?2016/7/4/159/191428
| Introduction|| |
Cancer is one of the most life-threatening and complex diseases involving cell transformations, dysregulation of apoptosis, proliferation, invasion, angiogenesis, and metastasis.  Breast cancer is the second most common type of cancer diagnosed in developing countries and most common malignancy type diagnosed in developed countries. According to the International Agency for Research on Cancer in 2008, there were approximately 1.38 million new cases of breast cancer, and by the end of 2020, this figure is expected to escalate to 1.7 million.  Despite the recent advancements in currently available therapies including radiation, chemotherapy, immunomodulation, and surgery, there is an imperative need for alternative strategies for efficient cancer management.
Wrightia tinctoria Roxb. (R.Br.) (Apocynaceae) is used in Ayurvedic, Unani, and Siddha medicines as an astringent, febrifuge, and tonic. The bark is very effective in seminal weakness, flatulence and also used in piles and skin diseases.  Available literature revealed that only a little work had been reported on the anticancer activity of the bark of this plant, except some primary information regarding crude extract and petroleum ether and ethyl acetate fraction. , In the present study, we investigated the anticancer and antioxidant potentials of W. tinctoria bark methanolic extract (WTBM) against estrogen receptor (ER)-positive breast adenocarcinoma MCF-7 and triple-negative MDA-MB-231 cells and determination of polyphenolic compounds by high-performance liquid chromatography-diode array detector (HPLC-DAD).
| Materials and methods|| |
Collection of plant material and extract preparation
The bark of W. tinctoria was collected from Ahraura, Mirzapur District, Uttar Pradesh, India, and identified by Dr. Sharad K. Srivastava, Department of Pharmacognosy, NBRI, Lucknow. The powdered plant material was percolated in 95% methanol; after 72 h, combined extract was filtered and concentrated under reduced pressure and controlled temperature on a rotatory evaporator. The residue obtained dried completely and named as WTBM and kept in a desiccator for further study.
Screening of WTBM for the presence of various phytochemical constituents was evaluated as standard method described by Trease and Evans, 1989. 
Human breast cancer MDA-MB-231 (human breast adenocarcinoma, triple-negative, tumorigenic, and invasive) and MCF-7 (human breast adenocarcinoma, ER-positive, and invasive) cells were obtained from ATCC, USA, and cultured with Roswell Park Memorial Institute medium supplemented with 5% fetal bovine serum (FBS) and 10% FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin, in a humidified 5% CO 2 incubator at 37°C.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
MDA-MB-231and MCF-7 (5000 cells per well) cells were seeded in 96-well culture plate at 37°C for 24 h, followed by treatment with different concentrations of WTBM and cisplatin (positive control) in triplicate. 10 μl of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (5.0 mg/ml in phosphate-buffered saline [PBS]) was added to each well and further incubated for 3-4 h. Medium containing MTT was gently aspirated and dimethyl sulfoxide (100 μl/well) was added to dissolve the formazan crystal and absorbance was measured at 540 nm.
Morphological changes in MDA-MB-231and MCF-7 cells after the treatment with WTBM were studied by phase-contrast inverted microscope. Cells shrinkage, membrane blebbing, chromatin condensation, and fragmentation were observed.
Colony formation assay
To determine the growth inhibition effects, MDA-MB-231 and MCF-7 cells were treated with different concentrations (25-200 μg/ml) of WTBM for 24 h. Colonies formed after 7 d were fixed with 4% paraformaldehyde, stained with 0.05% Coomassie blue, and counted under an inverted microscope. The following formula was used to calculate the colony inhibition rate:
Colony inhibition rate (%) = ([Colony number of control group − Colony number of treated group/Colony number of control group] × 100)
Hoechst 33342 staining
Changes in nuclear morphology of MDA-MB-231and MCF-7 cells after WTBM treatment were evaluated with the help of Hoechst 33342 staining. Briefly, cells (200 cells per well) were grown on coverslip in a six-well plate and treated with different concentrations (12.5-50 μg/ml) of WTBM for 18-20 h. Cells were harvested and fixed with 4% paraformaldehyde for 15 min at 4°C. Cells were then washed with ice-cold PBS three times and stained with Hoechst 33342 dye (1 μg/ml in PBS) and incubated for 2 min in the dark, at room temperature. Fixed cells were again washed three times with ice-cold PBS and observed under a phase-contrast and fluorescence inverted microscope with standard excitation filters.
Total phenolic content
Total phenolic content of WTBM was estimated by Folin-Ciocalteu reagent as determined by Singleton and Rossi with slight modifications.  In brief, 0.1 ml of WTBM (1 mg/ml) was added to 1 ml 10% Folin-Ciocalteu reagent and incubated for 5 min. After 5 min, 0.8 ml solution of Na 2 CO 3 (10% w/v in distilled water) was added and incubated for 15 min; thereafter, absorbance was measured at 765 nm. The total concentration of phenolic content in the tested extract was determined as the gallic acid equivalent (GAE) mg/g of dry extract.
2,2-diphenyl-1-picrylhydrazyl and 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid radical scavenging activity
Different working concentrations (12.5-800 μg/ml) of WTBM and standard (ascorbic acid) were prepared from stock solution (1.0 mg/ml) in 1.0 ml volume in a test tube. Then, 1.0 ml of 2,2-diphenyl-1-picrylhydrazyl (DPPH) solution (0.1 mM) was added to each test tube and was shaken gently. Mixture stands for 20-30 min and absorbance was taken at 517 nm using an ultraviolet-visible spectrophotometer.
The 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radical cation (ABTS + ) solution was prepared by the mixing of 7 mM ABTS and 2.45 mM potassium persulfate after incubation at 23°C in the dark for 16 h. 3.9 ml ABTS + solution (absorbance = 0.700 ± 0.005) was added to 0.1 ml of the different concentrations of WTBM and incubated for 6 min; thereafter, absorbance at 734 nm was recorded. Rutin was used as positive control. The absorbance was recorded for each concentration, and percent quenching of DPPH and ABTS was calculated.
Radical scavenging activity (%) = ([A 0 − A 1 /A 0 ] × 100)
Where A 0 was the absorbance of the control (blank, without compound) and A 1 was the absorbance of the compound.
High-performance liquid chromatography analysis
The phenolic compounds (gallic acid, rutin, and quercetin) in WTBM were determined with the help of an HPLC equipped with an integrated system with Agilent 1260 Infinity HPLC-DAD. Data were analyzed using Agilent ChemStation revision B.04.01 software (Agilent Technologies, Santa Clara, CA 95051. United States). The chromatographic separation was achieved with the Agilent Zorbax C-18 (4.6 mm × 250 mm, 5 μm) column thermostated at 25°C. For gradient elution, two solvents were used; one of these consists of 0.3% HCOOH in water and the other was consists of only methanol. 10 mg of crude extract was dissolved in 10 ml methanol for each sample to achieve a concentration of 1 mg/ml. The injection volume and flow rate were 5 μl and 1.0 ml/min, respectively, and detection was carried at 280 nm by DAD.
| Results|| |
The qualitative preliminary phytochemical analysis revealed that the WTBM showed a positive test for alkaloids, tannin, terpenes, steroids, coumarins, and flavonoids. However, glycosides and saponins were absent.
Effect of Wrightia tinctoria bark methanolic extract on proliferation of breast cancer cells
To assess antiproliferation activity, MDA-MB-231 and MCF-7 cells were exposed to increasing dose of WTBM for 24, 48, and 72 h. We observed dose- and time-dependent cytotoxic effects of WTBM on cells viability. WTBM caused 2.1 ± 0.6-68.16 ± 0.65% and 9.21 ± 2.6-69.41 ± 1.39% growth inhibition in MDA-MB-231 and MCF-7 cells, respectively, at the concentration ranged from 6.25 to 400 μg/ml after 24 h and exposure. However, IC 50 for MDA-MB-231 cells was 88.9 ± 1.27 μg/ml and for MCF-7 cells was 45.71 ± 7.74 μg/ml after 24 h of exposure [Figure 1]. We observed a decrease in IC 50 values for MDA-MB-231 and MCF-7, 60.7 ± 8.4 μg/ml and 37.03 ± 4.62 μg/ml, respectively, after 48 h of WTBM treatment, while standard cisplatin showed the IC 50 of 41.91 ± 2.13 μg/ml and 13.5 ± 1.39 μg/ml, respectively, for MDA MB-321 and MCF-7 cells.
|Figure 1: Wrightia tinctoria bark methanolic extract inhibited proliferation in MDA-MB-321 and MCF-7 cells. Cell viability in treated cells versus untreated cells was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay after 24, 48, and 72 h of incubation. The data were represented as the mean ± standard deviation (n = 3)|
Click here to view
Effect of Wrightia tinctoria bark methanolic extract on morphological changes by phase-contrast inverted microscope
Morphological changes of MDA-MB-231 and MCF-7 cells upon exposure using WTBM was observed. Usually, cells undergoing apoptosis display a similar pattern of morphological changes including blebbing, loss of cell membrane symmetry and attachment, chromatin condensation and fragmentation, and cell shrinkage; however, untreated cells did not show the apparent apoptotic morphological changes. As the concentration increased, enlargement of cells was conspicuously observed [Figure 2].
|Figure 2: Morphological changes of MDA-MB-321 cells and MCF-7 cells after treatment with Wrightia tinctoria bark methanolic extract for 24 h and imaged by inverted phase-contrast microscope|
Click here to view
Effect of Wrightia tinctoria bark methanolic extract on colony formation of breast cancer cells
To further investigate the antiproliferative effect of WTBM, the colony formation assay was used to assess the survival of tumorigenic cells. At the concentration range of 25 μg/ml to 400 μg/ml, colony formation was significantly reduced in WTBM treated cells when compared to control/untreated cells [Figure 3]. A significant decrease of 17.63%-72.02% and 15.4%-98.16% were observed after the treatment of WTBM against MDA-MB-231 and MCF-7 cells showing dose-dependent antiproliferative activity.
|Figure 3: Wrightia tinctoria bark methanolic extract inhibited colony formation in MDA-MB-321 and MCF-7 cells. Cells were seeded into 6-well plate, treated with various concentrations of Wrightia tinctoria bark methanolic extract for 24 h, fixed and stained with 4% paraformaldehyde and 0.05% Coomassie blue|
Click here to view
Effect of Wrightia tinctoria bark methanolic extract on morphological changes and quantification of apoptosis by Hoechst 33342 staining by fluorescence microscope
Hoechst 33342 staining in MDA-MB-231 and MCF-7 cells revealed that both cells possess marked morphological changes in a dose-dependent manner after exposure to WTBM. In untreated cells, slightly blue and homogeneous cells with intact normal nuclei were observed [Figure 4], while in the case of treated cells, the blue fluorescence was much brighter due to nuclear morphological changes. Significant changes such as cell shrinkage, chromatin condensation and fragmentation, and abnormal morphology in cells were observed.
|Figure 4: Wrightia tinctoria bark methanolic extract induced apoptosis cell death in MDA-MB-231 and MCF-7 cells. Detection of morphological apoptosis with Hoechst 33342 staining. Cell morphology was observed under a fluorescence microscope. Arrows indicate the cells with DNA fragmentation|
Click here to view
Total phenolic content
Total phenolic content was determined in comparison with standard gallic acid, and the results were expressed in terms of mg GAE/g dry extract. Total phenolic content (TPC) was found to be 30.3 GAE mg/g dry weight of bark extract.
Effect of Wrightia tinctoria bark methanolic extract on 2,2-diphenyl-1-picrylhydrazyl and 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid-free radicals
The results of DPPH radical scavenging activity are expressed as percentage inhibition of DPPH radical. At the concentration ranged from 12.5 to 800 μg/ml, the scavenging activity of WTBM was 4.37%-85.6%. The WTBM exhibited high free radical scavenging activity with an IC 50 valve of 72.2 ± 2.8 μg/ml [Figure 5]. The efficiency of inhibition was compared with standard ascorbic acid with an IC 50 value of 2.04 ± 0.1 μg/ml.
|Figure 5: Percent inhibition of 2,2-diphenyl-1-picrylhydrazyl free radical and 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid radical after treatment with Wrightia tinctoria bark methanolic extract. The data were represented as the mean ± standard deviation (n = 3)|
Click here to view
The scavenging activity of ABTS radical by WTBM is shown in [Figure 5]. The data clearly indicated that WTBM is an effective scavenger of ABTS radical and this activity is comparable to rutin. At the concentration range of 12.5-800 μg/ml, the ABTS radical scavenging activity of WTBM was found to be 12.49%-83.24%. The IC 50 value of rutin was found to be 4.31 ± 0.56 μg/ml while IC 50 value of WTBM was 45.16 ± 1.95 μg/ml.
High-performance liquid chromatography analysis
Among all the polyphenols analyzed, concentration of rutin (2.181 ± 0.09 μg/gm of dry weight) was highest, followed by quercetin (1.861 ± 0.06 μg/g of dry weight) and gallic acid (0.28 ± 0.2 μg/g of dry weight) in WTBM [Figure 6].
|Figure 6: High-performance liquid chromatography chromatogram of gallic acid, rutin, and quercetin (a and b) standard and three-dimensional view. (c and d) Wrightia tinctoria bark methanolic extract and three-dimensional view of the chromatogram. Zorbax Eclipse ODS C-18 column, gradient eluents methanol and water, injection volume 5.0 μl with a flow rate of 1.0 ml/min, detection at 280 nm|
Click here to view
| Discussion|| |
The management of triple-negative breast cancer is ever challenging due to its highly aggressive nature, limited treatment options, and extremely poor prognosis. The apoptotic and antiproliferative effects of WTBM on triple-negative and highly aggressive MDA-MB-231 cells are intriguing. We observed typical morphological change such as cell shrinkage, nuclear condensation, and formation of round apoptotic bodies in both MDA-MB-231 and MCF-7 cells after exposure with WTBM. These findings suggest the involvement of apoptotic pathways behind antiproliferative property; however, more in-depth studies are needed to understand molecular cascades and apoptotic signaling induced by W. tinctoria. Although we have not tested the cytotoxic effect of W.tinctoria on non-tumorigenic cells. However, this plant has been widely used in India for the treatment of various disorders without any observed toxicity as clearly indicated by a study on acute oral cytotoxicity by Jain and Bari 2011, using a very high oral dose of 2500 mg/kg crude extract showed no mortalities or adverse effects in mice. 
Natural chemopreventive agents exhibiting antiproliferative and apoptotic effects on cancer cells usually have antioxidant property that targets signaling molecules, protecting or preventing cells from further damage or transforms into cancerous cells.  Free radical scavenging assay demonstrated that W. tinctoria exhibited the potent inhibitory property of DPPH and ABTS free radicals in a concentration-dependent manner. There are many reports demonstrating the protective role of antioxidants in cancer. It has been reported that supplementation with antioxidants and vitamins decreases incidence of cancer, and dietary phytochemicals slow down progression of cancer.  Due to its potent antiradical property, W. tinctoria may act as an external antioxidant and prevent propagation of reactive oxygen species-initiated cellular damage. There is accumulating evidence indicating that natural compounds not only offer protection against oxidative reactions but also suppress cell proliferation in both in vivo and in vitro preclinical models. 
Phenols are most important antioxidants due to their idyllic structure chemistry for free radical scavenging activity; they can act as reducing agents, metal chelators, and free radical quenchers either by donating a hydrogen atom or electron to free radicals or by quenching singlet or triplet oxygen or decomposing peroxides.  The high amount of TPC present in W. tinctoria (30.3 mg/g) may contribute to its antiproliferative and free radical scavenging properties. The phytochemical analysis of W. tinctoria revealed the presence of three major groups of polyphenolic compounds, i.e. phenols, flavonoids, and tannins, which may provide a synergetic effect to enhance its anticancer properties. Gallic acid selectively induces apoptosis in various cancer cells.  Rutin is a bioflavonoid that inhibits carcinogenic processes and a potent chemotherapeutic agent.  Quercetin also has been reported to possess antiproliferative activity against different cancer cells.  The presence of gallic and other flavonoid compounds (rutin and quercetin) in W. tinctoria bark significantly contributes its anticancer and antioxidant properties.
| Conclusion|| |
In conclusion, our study provides compelling evidences that W. tinctoria bark extract showed significant inhibitory potential against breast cancer cells. The antiproliferative activity of W. tinctoria is highly concurrent with apoptosis induction in breast cancer. On the basis of our results it may be stated that the cell inhibiting potential and apoptotic properties of W. tinctoria in breast cancer cells may be due to the presence of different phytochemicals and phenolic contents. However, further studies are needed to isolate and identify W. tinctoria active compounds and to unveil its mechanism involved in breast cancer inhibition
Financial support and sponsorship
The author would like to thank Department of Science & Technology, New Delhi for providing financial grant (SR/WOS-A/CS-109/2013) to carry out this research work.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Nath R, Roy S, De B, Choudhury MD. Anticancer and antioxidant activity of croton: A review. Int J Pharm Sci 2013;5:63-70.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
Khyade MS, Vaikos NP. Wrightia tinctoria
R. Br. A review on its ethnobotany, pharmacognosy and pharmacological profile. J Coast Life Med 2014;2:826-40.
Jain R, Jain SK. Screening of in vitro
cytotoxic activity of some medicinal plants used traditionally to treat cancer in Chhattisgarh state, India. Asian Pac J Trop Biomed 2011;1:147-50.
Chaudhary S, Devkar RA, Bhere D, Setty MM, Pai KS. Selective cytotoxicity and pro-apoptotic activity of stem bark of Wrightia tinctoria
(Roxb.) R. Br. in cancerous cells. Pharmacogn Mag 2015;11 Suppl 3:S481-7.
Trease GE, Evans WC. Pharmacognosy. 11 th
ed. London: Bailliere Tindall; 1989. p. 45-50.
Singeleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic phosphotungstic acid reagents. Am J Enol Vitic 1965;16:144-58.
Jain PS, Bari SB. Evaluation of wound healing effect of petroleum ether and methanolic extract of Abelmoschus manihot
(L.) Medik., Malvaceae
and Wrightia tinctoria
R. Br., Apocynaceae
in rats. Rev Bras Farmacogn 2010;20:756-61.
Khan N, Afaq F, Mukhtar H. Apoptosis by dietary factors: The suicide solution for delaying cancer growth. Carcinogenesis 2007;28:233-9.
Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999;4:304-29.
Siriwardhana N, Lee KW, Kim SH, Ha JW, Jeon YJ. Antioxidant activity of Hizikia fusiformis
on reactive oxygen species scavenging and lipid peroxidation inhibition. Food Sci Technol Int 2003;9:339-46.
Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993;49:481-93.
Locatelli C, Filippin-Monteiro FB, Creczynski-Pasa TB. Alkyl esters of gallic acid as anticancer agents: A review. Eur J Med Chem 2013;60:233-9.
Al-Dhabi NA, Arasu MV, Park CH, Park SU. An up-to-date review of rutin and its biological and pharmacological activities. EXCLI J 2015;14:59-63.
Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, et al.
Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med 2011;2011:591356.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]
|This article has been cited by|
||Specialized plant metabolites from indolic and polyphenolic biosynthetic pathways in Wrightia religiosa (Teijsm. & Binn.) Benth. and Wrightia pubescens R. Br. (Apocynaceae)
| ||Florian Traxler,Nitkamon Iamprasertkun,Anna Maria Tschigg,Srunya Vajrodaya,Karin Valant-Vetschera,Lothar Brecker,Johann Schinnerl |
| ||South African Journal of Botany. 2021; 137: 242 |
|[Pubmed] | [DOI]|
||GC-MS Analysis and Antioxidant Activity of Wrightia tinctoria R.Br. Leaf Extract
| ||Nausheen Khan,Amena Ali,Abdul Qadir,Athar Ali,Musarrat Husain Warsi,Abu Tahir,Abuzer Ali |
| ||Journal of AOAC INTERNATIONAL. 2021; |
|[Pubmed] | [DOI]|